Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARK2 pseudogene 10 (MARK2P10) is a processed pseudogene identified by homology to the protein-coding gene MARK2, which is a serine/threonine kinase involved in cell polarity, microtubule dynamics, and various signaling pathways[4][5]. Unlike MARK2, MARK2P10 is not known to produce any functional protein product and has no established biological or disease association. Pseudogenes such as MARK2P10 typically arise through duplication or retrotransposition events and generally accumulate mutations that disable protein expression. There is no evidence that MARK2P10 has any role as a biomarker, drug target, or disease gene, nor is it involved in any molecular mechanism of action relevant to therapeutics or diagnostics[4][5][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARK2 pseudogene 10 (MARK2P10).